- Custom synthesis of 14C labelled compounds to support pre-clinical ADME studies
- GMP synthesis of 14C labelled compounds for human AME studies
- Expertise and facilities for handling labelled gases and volatiles including Carbon Dioxide, Carbon Monoxide and Methyl Iodide.
Projects can be supported either by separate complete syntheses of non-clinical and clinical batches, or by synthesis of a pre-clinical intermediate, which can be used to prepare non-clinical and clinical batches. This second approach can avoid the need for a re-synthesis, saving both time and cost when providing labelled material for the hAME study.
Bio SpainBioSpain 2018 will be attended by Nathalie Huther, Business Development Manager Europe.
Bio SpainDates: 25th - 27th SeptemberLocation: Seville, Spain
BioForwardThe BioForward event will be attended by Nathalie Huther, Business Development Manager Europe.
BioForwardDates: 4th OctoberLocation: Birmingham, UK
CPhI WorldwideCPhI Worldwide will be attended by Nathalie Huther, Business Development Manager Europe. Nathalie will be located at the DIT stand: 9J40
CPhI WorldwideDates: 9th - 11th OctoberLocation: Madrid, Spain